Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon

Am J Respir Crit Care Med. 2020 Jun 15;201(12):1564-1568. doi: 10.1164/rccm.201909-1819LE.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Clofazimine / therapeutic use*
  • Diarylquinolines / therapeutic use*
  • Drug Resistance, Multiple, Bacterial / genetics
  • Germany
  • Humans
  • Mycobacterium tuberculosis / genetics
  • Practice Guidelines as Topic
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • World Health Organization

Substances

  • Antitubercular Agents
  • Diarylquinolines
  • bedaquiline
  • Clofazimine